Drug Profile
Haemoglobin - liposomal
Latest Information Update: 05 Dec 2021
Price :
$50
*
At a glance
- Originator Nonindustrial source
- Class
- Mechanism of Action Haemoglobin stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Hypovolaemia